The estimated Net Worth of Stephen Ray Mitchell is at least $306 Tisíc dollars as of 10 August 2023. Stephen Mitchell owns over 6,500 units of Vanda Pharmaceuticals Inc stock worth over $144,294 and over the last 5 years he sold VNDA stock worth over $162,021. In addition, he makes $0 as Independent Director at Vanda Pharmaceuticals Inc.
Sign up
Stephen Mitchell VNDA stock SEC Form 4 insiders trading
Stephen has made over 4 trades of the Vanda Pharmaceuticals Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently he sold 6,500 units of VNDA stock worth $39,325 on 10 August 2023.
The largest trade he's ever made was exercising 19,109 units of Vanda Pharmaceuticals Inc stock on 9 September 2021 worth over $229,881. On average, Stephen trades about 3,331 units every 79 days since 2020. As of 10 August 2023 he still owns at least 29,328 units of Vanda Pharmaceuticals Inc stock.
You can see the complete history of Stephen Mitchell stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Stephen Mitchell biography
Dr. Stephen Ray Mitchell M.D. serves as Independent Director of the Company. Dr. Mitchell currently serves as the Joseph Butenas Professor and Dean for Medical Education at Georgetown University School of Medicine, a position he has held since August 2002. Prior to that, Dr. Mitchell served as Associate Dean for Clinical Curriculum at Georgetown University School of Medicine from 1998 to 2000 and as Senior Associate Dean for Academic Affairs from 2000 until 2002. Previously, Dr. Mitchell served as Program Director for Internal Medicine at Georgetown University School of Medicine from 1992 until 1997, and as Founding Program Director Med-Peds at Georgetown from 1995 until 1999. He served as a member of the Liaison Committee for Medical Education (the “LCME”), the national accrediting body for Medical Schools in the United States and Canada, between 2013 and 2019. Since 2018, he has held the role of Chair of the LCME, where he chaired the Standards subcommittee, and now serves as a member of the Governing Council of that body. Dr. Mitchell is a veteran of the United States Air Force, and has served as author and invited external reviewer on Studies by the Institute of Medicine on Chronic Multi-symptoms illness in Gulf War veterans. Dr. Mitchell received his B.A. in Psychology and his M.D. from the University of North Carolina at Chapel Hill, and his Global Executive M.B.A. from The McDonough School of Business at Georgetown University. Mitchell’s qualifications to sit on the Board include his extensive experience in the medical field and leadership positions at leading medical institutions.
How old is Stephen Mitchell?
Stephen Mitchell is 68, he's been the Independent Director of Vanda Pharmaceuticals Inc since 2020. There are 1 older and 14 younger executives at Vanda Pharmaceuticals Inc. The oldest executive at Vanda Pharmaceuticals Inc is Richard Dugan, 78, who is the Independent Director.
What's Stephen Mitchell's mailing address?
Stephen's mailing address filed with the SEC is C/O VANDA PHARMACEUTICALS INC., 2200 PENNSYLVANIA AVENUE, SUITE 300E, WASHINGTON, DC, 20037.
Insiders trading at Vanda Pharmaceuticals Inc
Over the last 19 years, insiders at Vanda Pharmaceuticals Inc have traded over $267,060,716 worth of Vanda Pharmaceuticals Inc stock and bought 5,567,934 units worth $25,606,507 . The most active insiders traders include Kevin Ctang Capital Managem..., Nicole Vitullo a Jesse I Treu. On average, Vanda Pharmaceuticals Inc executives and independent directors trade stock every 31 days with the average trade being worth of $546,607. The most recent stock trade was executed by Kevin Patrick Moran on 29 July 2024, trading 2,251 units of VNDA stock currently worth $13,326.
What does Vanda Pharmaceuticals Inc do?
vanda is a specialty pharmaceutical company focused on the development and commercialization of novel therapies to address high unmet medical needs and improve the lives of patients.
What does Vanda Pharmaceuticals Inc's logo look like?
Complete history of Stephen Mitchell stock trades at Vanda Pharmaceuticals Inc
Vanda Pharmaceuticals Inc executives and stock owners
Vanda Pharmaceuticals Inc executives and other stock owners filed with the SEC include:
-
Mihael Polymeropoulos,
President, Chief Executive Officer, Director -
Timothy Williams,
Senior Vice President, General Counsel, Secretary -
Gunther Birznieks,
Senior Vice President - Business Development -
Dr. Mihael H. Polymeropoulos M.D.,
Founder, Pres, CEO & Chairman of The Board -
Dr. Mihael H. Polymeropoulos,
Founder, Pres, CEO & Director -
Joakim Wijkstrom,
Sr. VP & Chief Marketing Officer -
Kevin Patrick Moran,
Sr. VP, CFO & Treasurer -
Timothy Williams,
Sr. VP, Gen. Counsel & Sec. -
Phaedra Chrousos,
Independent Director -
Anne Ward,
Independent Director -
H. Thomas Watkins,
Independent Chairman of the Board -
Richard Dugan,
Independent Director -
Stephen Mitchell,
Independent Director -
Aranthan Jones,
Chief Corporate Affairs and Communications Officer -
Joakim Wijkstrom,
Senior Vice President, Chief Marketing Officer -
Kevin Moran,
Acting Chief Financial Officer, Vice President, Treasurer -
Elizabeth Van Every,
Head of Corp. Affairs -
Scott L. Howell,
Chief People Officer -
Kenneth Bate,
Director -
Michael F Cola,
Director -
James E Deerfield Mgmt L.P....,
-
Paolo Baroldi,
Chief Medical Officer -
Vincent Milano,
Director -
Steven A Shallcross,
Sr. VP, CFO, Treasurer -
Albert W. Gianchetti,
Sr.VP,Chief Commercial Officer -
Tage Honore,
-
Richard L. Gulino,
SVP & General Counsel -
James Patrick Kelly,
EVP & Chief Financial Officer -
Gian Piero Reverberi,
SVP & Chief Commercial Officer -
James B Tananbaum,
Director -
Capital Ii Llccare Capital ...,
-
Robert J More,
10% owner -
Nicole Vitullo,
10% owner -
Management Co Ii Llcprospec...,
-
Brian H Dovey,
10% owner -
Deepak Shripad Phadke,
Vice President Manufacturing -
Ventures Iv Lprho Ventures ...,
-
James C Blair,
10% owner -
Inc /De Medimmune,
10% owner -
Wayne T Hockmeyer,
Director -
Ventures Iv Lprho Managemen...,
-
Vi Associates, L.P. Dp,
10% owner -
Partners Vi, L.P. Domain,
10% owner -
Venture Partners Ii Lpprosp...,
-
Jesse I Treu,
10% owner -
Sciences Investment Fund Pt...,
-
Kathleen K Schoemaker,
10% owner -
Thomas Edward Gibbs,
SVP, Chief Commercial Officer -
James E Deerfield Mgmt L.P....,
-
Howard H Pien,
Director -
Steven K Galson,
Director -
Robert Repella,
SVP & Chief Commercial Officer -
Stephanie Rast Irish,
Sr. VP, Acting CFO/Treasurer -
John Joseph Feeney,
Acting Chief Medical Officer -
Argeris N Karabelas,
Chairman of the Board -
Brian K Halak,
Director -
William D Clark,
Sr VP, Chief Business Officer -
David Russ Ramsay,
Director -
Kevin Ctang Capital Managem...,